NIH-funded research R21 grant

Understanding how CSPalpha affects brain cell health and function

Official title: Investigating the role of CSPalpha in presynaptic autophagy

Funded at Yale University · NIH-11116139 · Data updated 2026-11-12

This study is looking at a protein called CSPα to see how it helps keep brain cells healthy by cleaning up damaged proteins, which could help us understand more about diseases like Alzheimer's and find new ways to treat them.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startJune 1, 2025
Project endMay 31, 2027
Funding year2025
Award (this year)$461,313
NIH project number1R21AG093151-01
Project IDNIH-11116139 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over 21 years old who are experiencing symptoms of Alzheimer's disease or related dementias.

Less likely to help

Patients with neurodegenerative conditions unrelated to protein folding or synaptic health may not benefit from this research.

What this research studies

This research investigates the role of Cysteine String Protein α (CSPα) in maintaining the health of brain cells, particularly focusing on its involvement in the process of autophagy, which is crucial for clearing damaged proteins. By studying both normal and mutated forms of CSPα in brain models, the research aims to uncover how disruptions in this protein contribute to neurodegenerative diseases like Alzheimer's. The team will utilize advanced techniques such as electron microscopy and live imaging to observe changes in synaptic structures and protein turnover. This work could provide insights into the mechanisms of neurodegeneration and potential therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating neurodegenerative diseases like Alzheimer's.

How similar studies have gone: Previous research has shown promising results in understanding the role of protein chaperones in neurodegeneration, indicating that this approach has potential for success.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Chandra, Sreeganga S — Yale University
  • Study coordinator: Chandra, Sreeganga S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.